Patrick Fourteau Net Worth & Insider Trades

Patrick Fourteau - Director, Insys Therapeutics, Inc

As of August 4, 2017

What is Patrick Fourteau's Net Worth?

The current estimated net worth of Insys Therapeutics, Inc's Director, Patrick Fourteau, is estimated to be about $4.17M . Patrick Fourteau owns about 49,682 units of Insys Therapeutics, Inc common stock. In the last 2 years at Insys Therapeutics, Inc, Patrick Fourteau has sold an estimated value of $2.85M worth.

What is Patrick Fourteau's Past Insider Trading?

Patrick Fourteau's largest sale order was 30,000 units , worth over $794.4K on November 13, 2015. In total, Patrick Fourteau has made about 11 transactions over 2 years of their time at Insys Therapeutics, Inc. Patrick Fourteau usually trades in May, with the busiest year in 2015. The most recent transaction was a sale order of 15,000 units , worth over $276.9K on August 12, 2016.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PATRICK FOURTEAU

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What are Insys Therapeutics, Inc's Past Insider Trades?

Insys Therapeutics, Inc's most recent insider trade came on May 14, 2018 by Brian Tambi who sold 166,504 units worth $1.07M . In the last 3 years, insiders at Insys Therapeutics, Inc have sold an estimated value of $14.52M and bought an estimated value of $3.92M worth of shares. Insider trading is most common in May, with the busiest year in 2015. The most active traders at the company are Steven Meyer, Director,  Patrick Fourteau, Director,  and John Kapoor .

Insys Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...